A comparison of the protective effect of vaccination and clinical features between the SARS-CoV-2 wild-type strain and Delta (B.1.617.2) variant
- PMID: 36457976
- PMCID: PMC9710252
- DOI: 10.5114/aoms/155114
A comparison of the protective effect of vaccination and clinical features between the SARS-CoV-2 wild-type strain and Delta (B.1.617.2) variant
Abstract
Introduction: This study aimed to investigate the clinical features and vaccine effectiveness of patients with the SARS-CoV-2 wild-type strain and the Delta variant.
Methods: We retrospectively evaluated patients with the SARS-CoV-2 wild-type strain and the Delta variant.
Results: The Delta-variant group showed a higher infection rate in minors, who had higher incidence of anosmia or dysgeusia and shorter incubation period. Unvaccinated patients had a 15.59-fold higher risk of severe classification than vaccinated patients. The viral clearance time was significantly shorter in the Delta-variant group.
Conclusions: The Delta-variant group show higher transmissibility, and vaccination reduces the incidence of severe classification and promotes viral clearance.
Keywords: COVID-19; SARS-CoV-2; clinical feature; pandemic; transmission; vaccine.
Copyright: © 2022 Termedia & Banach.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.medRxiv [Preprint]. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268. medRxiv. 2021. Update in: J R Soc Interface. 2022 Jun;19(191):20210900. doi: 10.1098/rsif.2021.0900. PMID: 34845460 Free PMC article. Updated. Preprint.
-
Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.Microbiol Spectr. 2022 Apr 27;10(2):e0000822. doi: 10.1128/spectrum.00008-22. Epub 2022 Apr 12. Microbiol Spectr. 2022. PMID: 35412379 Free PMC article.
-
SARS-CoV-2 Delta Variant in Jingmen City, Hubei Province, China, 2021: Children Susceptible and Vaccination Breakthrough Infection.Front Microbiol. 2022 Apr 13;13:856757. doi: 10.3389/fmicb.2022.856757. eCollection 2022. Front Microbiol. 2022. PMID: 35495649 Free PMC article.
-
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35143466 Free PMC article.
-
Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China.Int J Infect Dis. 2022 Mar;116:204-209. doi: 10.1016/j.ijid.2022.01.030. Epub 2022 Jan 19. Int J Infect Dis. 2022. PMID: 35065255 Free PMC article.
References
-
- Kadri SS, Simpson SQ. Potential implications of SARS-CoV-2 Delta variant surges for rural areas and hospitals. JAMA 2021; 326: 1003-4. - PubMed
-
- Rajabimajd N, Alimoradi Z, Griffiths MD. Impact of COVID-19-related fear and anxiety on job attributes: a systematic review. Asian J Soc Health Behav 2021; 4: 51-5.
LinkOut - more resources
Full Text Sources
Miscellaneous